Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Editorial Volume 7 Issue 3

Precision Therapy in Oncology

Mallik Singaraju*

Radiation Oncology, Continental Hospital, India

*Corresponding Author: Mallik Singaraju, Radiation Oncology, Continental Hospital, India.

Received: February 20, 2023; Published: April 01, 2023

Cancer is second most common cause of death in the world. As the technology is advancing, the number of newly diagnosed cancer cases are on raise. Especially, in advanced stage. A decade back, the treatment for advanced cancers was primarily by chemotherapeutic agents. But now, targeted therapies are becoming increasingly popular.

References

Citation

Citation: Mallik Singaraju. “Mutational Screening and Prenatal Diagnosis of β-thalassemia in Pakistani Families" Acta Scientific Cancer Biology 7.3 (2023): 01-02.

Copyright

Copyright: © 2023 Mallik Singaraju. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Reviewer Certificate
    Certificate will be issues to the valued reviewer who worked on the Articles Peer Review process.
  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit their manuscripts before September 30, 2025

Contact US